Market Overview: In 2022, the global sacral Neuromodulation market was valued at USD 1.03 Billion and is projected to reach USD 1.85 Billion by 2032, with a compound annual growth rate (CAGR) of 6.8% during the forecast period. The market growth is primarily attributed to the increasing prevalence of Overactive Bladder Syndrome (OAB), fecal incontinence, and chronic pelvic discomfort....
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian